Immunotherapy via PD-L1–presenting biomaterials leads to long-term islet graft survival

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,314 · see citing works

Safety, activity, and immune correlates of anti–PD-1 antibody in cancer

Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628 · see citing works

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy

Taube, J. M., Klein, A., Brahmer, J. R., Xu, H., Pan, X., Kim, J. H., Chen, L., Pardoll, D. M., Topalian, S. L., & Anders, R. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3271 · Cited by 2,324 · see citing works

The PD‐1 pathway in tolerance and autoimmunity

Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300 · see citing works

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity

Gordon, S. R., Maute, R. L., Dulken, B. W., Hutter, G., George, B. M., McCracken, M. N., Gupta, R., Tsai, J. M., Sinha, R., Corey, D., et al. (2017) · Nature · doi:10.1038/nature22396 · Cited by 2,247 · see citing works

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,072 · see citing works

International trial of the Edmonton protocol for islet transplantation

Shapiro, A. M. J., Ricordi, C., Hering, B. J., Auchincloss, H., Lindblad, R., Robertson, R. P., Secchi, A., Brendel, M. D., Berney, T., Brennan, D. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061267 · Cited by 1,942 · see citing works

Five-Year Follow-Up After Clinical Islet Transplantation

Ryan, E. A., Paty, B. W., Senior, P. A., Bigam, D., Alfadhli, E., Kneteman, N. M., Lakey, J. R. T., & Shapiro, A. M. J. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2060 · Cited by 1,641 · see citing works

Tumor Endothelium FasL Establishes a Selective Immune Barrier Promoting Tolerance in Tumors

Motz, G. T., Santoro, S. P., Wang, L.-P., Garrabrant, T., Lastra, R., Hagemann, I., Lal, P., Feldman, M., Benencia, F., & Coukos, G. (2014) · Nature Medicine · doi:10.1038/nm.3541 · Cited by 980 · see citing works

PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations

Jiang, Y., Chen, M., Nie, H., & Yuan, Y. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1571892 · Cited by 647 · see citing works

IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These Cells

Zheng, S. G., Wang, J., Wang, P., Gray, J. D., & Horwitz, D. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2018 · Cited by 597 · see citing works

The regulation of immune tolerance by FOXP3

Lu, L., Barbi, J., & Pan, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.75 · Cited by 580 · see citing works

Maleimide Cross‐Linked Bioactive PEG Hydrogel Exhibits Improved Reaction Kinetics and Cross‐Linking for Cell Encapsulation and In Situ Delivery

Phelps, E. A., Enemchukwu, N. O., Fiore, V. F., Sy, J. C., Murthy, N., Sulchek, T., Barker, T. H., & Garcı́a, A. J. (2011) · Advanced Materials · doi:10.1002/adma.201103574 · Cited by 541 · see citing works

Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity

Parman, T., Wiley, M. J., & Wells, P. G. (1999) · Nature Medicine · doi:10.1038/8466 · Cited by 495 · see citing works

Role of the PD-1 pathway in the immune response

Riella, L. V., Paterson, A. M., Sharpe, A. H., & Chandraker, A. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04224.x · Cited by 444 · see citing works

Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease

Attanasio, J., & Wherry, E. J. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.022 · Cited by 256 · see citing works

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

Restifo, N. P. (2000) · Nature Medicine · doi:10.1038/74955 · Cited by 251 · see citing works

Programmed Death-1 Targeting Can Promote Allograft Survival

Özkaynak, E., Wang, L., Goodearl, A. D. J., McDonald, K., Qin, S., O’Keefe, T. L., Duong, T., Smith, T., Gutierrez-Ramos, J.-C., Rottman, J. B., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6546 · Cited by 242 · see citing works

Programmed Cell Death-1 Inhibitor–Induced Type 1 Diabetes Mellitus

Clotman, K., Janssens, K., Specenier, P. M., Weets, I., & Block, C. E. M. D. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00728 · Cited by 235 · see citing works

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity

Axworthy, D. B., Reno, J. M., Hylarides, M. D., Mallett, R. W., Theodore, L. J., Gustavson, L. M., Su, F., Hobson, L. J., Beaumier, P. L., & Fritzberg, A. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1802 · Cited by 230 · see citing works

Microfluidic‐Based Generation of Size‐Controlled, Biofunctionalized Synthetic Polymer Microgels for Cell Encapsulation

Headen, D. M., Aubry, G., Lu, H., & Garcı́a, A. J. (2014) · Advanced Materials · doi:10.1002/adma.201304880 · Cited by 201 · see citing works

Tumor PD-L1 co-stimulates primary human CD8+ cytotoxic T cells modified to express a PD1:CD28 chimeric receptor

Prosser, M. E., Brown, C. E., Shami, A. F., Forman, S. J., & Jensen, M. C. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.03.023 · Cited by 186 · see citing works

Preventing Allograft Rejection by Targeting Immune Metabolism

Lee, C.-F., Lo, Y.-C., Cheng, C.-H., Furtmüller, G. J., Oh, B. C., Andrade‐Oliveira, V., Thomas, A. G., Bowman, C. E., Slusher, B. S., Wolfgang, M. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.036 · Cited by 177 · see citing works

Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance

Headen, D. M., Woodward, K. B., Coronel, M. M., Shrestha, P., Weaver, J. D., Zhao, H., Tan, M., Hunckler, M. D., Bowen, W. S., Johnson, C. T., et al. (2018) · Nature Materials · doi:10.1038/s41563-018-0099-0 · Cited by 175 · see citing works

Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites

Weaver, J. D., Headen, D. M., Aquart, J., Johnson, C. T., Shea, L. D., Shirwan, H., & García, A. J. (2017) · Science Advances · doi:10.1126/sciadv.1700184 · Cited by 170 · see citing works

Stimulating PD-1???negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival1

Gao, W., Demirci, G., Strom, T. B., & Li, X. C. (2003) · Transplantation · doi:10.1097/01.tp.0000085010.39567.fb · Cited by 158 · see citing works

Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin.

Breitz, H. B., Weiden, P. L., Beaumier, P. L., Axworthy, D. B., Seiler, C. A., Su, F., Graves, S. S., Bryan, K., & Reno, J. M. (2000) · PubMed · Cited by 151 · see citing works

Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes

Osum, K. C., Burrack, A. L., Martinov, T., Sahli, N. L., Mitchell, J. S., Tucker, C., Pauken, K. E., Papas, K. K., Balamurugan, A. N., Spanier, J. A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26471-9 · Cited by 147 · see citing works

PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes

Nasr, M. B., Tezza, S., D’Addio, F., Mameli, C., Usuelli, V., Maestroni, A., Corradi, D., Belletti, S., Albarello, L., Becchi, G., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7543 · Cited by 138 · see citing works

The Novel Costimulatory Programmed Death Ligand 1/B7.1 Pathway Is Functional in Inhibiting Alloimmune Responses In Vivo

Yang, J., Riella, L. V., Chock, S., Liu, T., Zhao, X., Yuan, X., Paterson, A. M., Watanabe, T., Vanguri, V. K., Yagita∥, H., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100056 · Cited by 134 · see citing works

TGFβ-dependent expression of PD-1 and PD-L1 controls CD8+ T cell anergy in transplant tolerance

Baas, M. C., Besançon, A., Goncalves, T., Valette, F., Yagita∥, H., Sawitzki, B., Volk, H., Waeckel-Énée, E., Rocha, B., Chatenoud, L., et al. (2016) · eLife · doi:10.7554/elife.08133 · Cited by 116 · see citing works

Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection.

Yolcu, E., Askenasy, N., Singh, N., Cherradi, S., & Shirwan, H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00482-x · Cited by 106 · see citing works

Mitigating hypoxic stress on pancreatic islets via in situ oxygen generating biomaterial

Coronel, M. M., Geusz, R. J., & Stabler, C. L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.03.018 · Cited by 104 · see citing works

Critical Role of Donor Tissue Expression of Programmed Death Ligand-1 in Regulating Cardiac Allograft Rejection and Vasculopathy

Yang, J., Popoola, J., Khandwala, S., Vadivel, N., Vanguri, V. K., Yuan, X., Dada, S., Guleria, I., Tian, C., Ansari, M. J., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.741025 · Cited by 96 · see citing works

Association Between Calcineurin Inhibitor Treatment and Peripheral Nerve Dysfunction in Renal Transplant Recipients

Arnold, R., Pussell, B. A., Pianta, T. J., Lin, C. S.-Y., Kiernan, M. C., & Krishnan, A. V. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12324 · Cited by 88 · see citing works

Protective Role of Programmed Death 1 Ligand 1 (PD-L1)in Nonobese Diabetic Mice

Wang, C.-J., Chou, F., Chu, C.-H., Wu, J., Lin, S., Chang, D., & Sytwu, H. (2008) · Diabetes · doi:10.2337/db07-1260 · Cited by 88 · see citing works

Immunosuppressive drugs after solid organ transplantation.

van Sandwijk, M. S., Bemelman, F. J., & ten Berge, I. J. M. (2013) · PubMed · Cited by 82 · see citing works

Engineering a Local Microenvironment for Pancreatic Islet Replacement

Coronel, M. M., & Stabler, C. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.05.004 · Cited by 67 · see citing works

Temporal Variations of Skin Pigmentation in C57Bl/6 Mice Affect Optical Bioluminescence Quantitation

Curtis, A., Calabro, K. W., Galarneau, J.-R., Bigio, I. J., & Krucker, T. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0440-8 · Cited by 63 · see citing works

Engineered single-chain dimeric streptavidins with an unexpected strong preference for biotin-4-fluorescein

Aslan, F. M., Yu, Y., Mohr, S. C., & Cantor, C. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503112102 · Cited by 54 · see citing works

Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility

Qian, C., Guo, H., Chen, X., Shi, A., Li, S., Wang, X., Pan, J., & Fang, C. (2018) · Journal of Diabetes Research · doi:10.1155/2018/1614683 · Cited by 42 · see citing works

Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression

Batra, L., Shrestha, P., Zhao, H., Woodward, K. B., Togay, A., Tan, M., Grimany-Nuno, O., Malik, M. T., Coronel, M. M., Garcı́a, A. J., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000055 · Cited by 42 · see citing works

CCR4 Controls the Suppressive Effects of Regulatory T Cells on Early and Late Events during Severe Sepsis

Molinaro, R., Silva, C. P. E., Guilherme, R. F., Alves-Filho, J. C., Cunha, F. Q., Canetti, C. D. A., Kunkel, S. L., Bozza, M. T., & Benjamim, C. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133227 · Cited by 32 · see citing works

Clinical Immunologic Interventions for the Treatment of Type 1 DiabetesPreprint

Chatenoud, L., Warncke, K., & Ziegler, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007716 · Cited by 30 · see citing works

PD-L1–Driven Tolerance Protects Neurogenin3-Induced Islet Neogenesis to Reverse Established Type 1 Diabetes in NOD Mice

Li, R., Lee, J., Kim, M. S., Liu, V., Moulik, M., Li, H., Yi, Q., Xie, A., Chen, W., Yang, L., et al. (2014) · Diabetes · doi:10.2337/db13-1737 · Cited by 28 · see citing works

B7-1 and B7-2 differentially control peripheral homeostasis of CD4+CD25+Foxp3+ regulatory T cells

Zeng, M., Guinet, E., & Nouri-Shirazi, M. A. (2008) · Transplant Immunology · doi:10.1016/j.trim.2008.09.009 · Cited by 28 · see citing works

The effects of FasL on inflammation and tumor survival are dependent on its expression levels

Wada, A., Tada, Y., Kawamura, K., Takiguchi, Y., Tatsumi, K., Kuriyama, T., Takenouchi, T., O‐Wang, J., & Tagawa, M. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701008 · Cited by 25 · see citing works

EFFECT OF A SHORT COURSE OF RAPAMYCIN, CYCLOSPORIN A, AND DONOR-SPECIFIC TRANSFUSION ON RAT CARDIAC ALLOGRAFT SURVIVAL

DAVIES, C. B., Madden, R., ALEXANDER, J. W., Cofer, B. R., FISHER, R. A., & ANDERSON, P. (1993) · Transplantation · doi:10.1097/00007890-199305000-00033 · Cited by 23 · see citing works

CCR4 dependent migration of Foxp3+ Treg cells to skin grafts and draining lymph nodes is implicated in enhanced graft survival in CD200tg recipients

Yu, K., Chen, Z., Khatri, I. A., & Gorczynski, R. M. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.09.002 · Cited by 22 · see citing works

ANALYSIS OF FUNCTIONAL RENAL ALLOGRAFT TOLERANCE WITH SINGLE-DOSE RAPAMYCIN BASED INDUCTION IMMUNOSUPPRESSION1

Goggins, W. C., Fisher, R. A., Dattilo, J. B., Cohen, D. S., Tawes, J. W., Dattilo, M. P. M., Babcock, G. F., Frede, S. E., Wakely, P. E., & Posner, M. P. (1997) · Transplantation · doi:10.1097/00007890-199701270-00023 · Cited by 15 · see citing works

Macrophage phenotypes in tissue repair and the foreign body response: Implications for biomaterial-based regenerative medicine strategies

Martin, K. E., & Garcı́a, A. J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.038 · Cited by 375 · see citing works

Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes

Hogrebe, N. J., Ishahak, M., & Millman, J. R. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.04.002 · Cited by 210 · see citing works

Biomaterials to enhance stem cell transplantation

Kharbikar, B. N., Mohindra, P., & Desai, T. A. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.04.002 · Cited by 183 · see citing works

Strategies for durable β cell replacement in type 1 diabetes

Brusko, T. M., Russ, H. A., & Stabler, C. L. (2021) · Science · doi:10.1126/science.abh1657 · Cited by 119 · see citing works

Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead

Grattoni, A., Korbutt, G., Tomei, A. A., García, A. J., Pepper, A. R., Stabler, C., Brehm, M., Papas, K., Citro, A., Shirwan, H., et al. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01029-0 · Cited by 92 · see citing works

Synthesis, properties, and biomedical applications of alginate methacrylate (ALMA)-based hydrogels: Current advances and challenges

Hasany, M., Talebian, S., Sadat, S., Ranjbar, N., Mehrali, M., Wallace, G. G., & Mehrali, M. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101150 · Cited by 90 · see citing works

Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

Burke, J. A., Zhang, X., Bobbala, S. K. R., Frey, M. A., Fuentes, C. B., Haddad, H. F., Allen, S. D., Richardson, R. A. K., Ameer, G. A., & Scott, E. A. (2022) · Nature Nanotechnology · doi:10.1038/s41565-021-01048-2 · Cited by 88 · see citing works

Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?

Bourgeois, S., Sawatani, T., Mulders, A. V., Leu, N. D., Heremans, Y., Heimberg, H., Cnop, M., & Staels, W. (2021) · Cells · doi:10.3390/cells10010191 · Cited by 61 · see citing works

Harnessing Biomaterials for Immunomodulatory-Driven Tissue Engineering

Zhong, J. X., Raghavan, P., & Desai, T. A. (2022) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-022-00279-6 · Cited by 65 · see citing works

Engineered immunomodulatory accessory cells improve experimental allogeneic islet transplantation without immunosuppression

Wang, X., Wang, K., Yu, M., Velluto, D., Hong, X., Wang, B., Chiu, A., Melero-Martin, J. M., Tomei, A. A., & Ma, M. (2022) · Science Advances · doi:10.1126/sciadv.abn0071 · Cited by 62 · see citing works

Local Immunomodulatory Strategies to Prevent Allo‐Rejection in Transplantation of Insulin‐Producing Cells

Wang, X., Brown, N. K., Wang, B., Shariati, K., Wang, K., Fuchs, S., Melero‐Martin, J. M., & Ma, M. (2021) · Advanced Science · doi:10.1002/advs.202003708 · Cited by 57 · see citing works

Biomaterials-assisted spheroid engineering for regenerative therapy

Lee, N., Bayaraa, O., Zechu, Z., & Kim, H. S. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.7.059 · Cited by 51 · see citing works

Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond

Abbaszadeh, S., Nosrati‐Siahmazgi, V., Musaie, K., Rezaei, S., Qahremani, M., Xiao, B., Santos, H. A., & Shahbazi, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115050 · Cited by 51 · see citing works

Advances in Cell Replacement Therapies for Diabetes

Hering, B. J., Rickels, M. R., Bellin, M. D., Millman, J. R., Tomei, A. A., Garcı́a, A. J., Shirwan, H., Stabler, C. L., Ma, M., Peng, Y., et al. (2025) · Diabetes · doi:10.2337/db25-0037 · Cited by 49 · see citing works

Biomaterials-Mediated Engineering of the Immune System

Backlund, C. M., Jalili‐Firoozinezhad, S., Kim, B., & Irvine, D. J. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-040259 · Cited by 48 · see citing works

Emerging immunomodulatory strategies for cell therapeutics

Chua, C. Y. X., Jiang, A. Y., Eufrásio-da-Silva, T., Dolatshahi‐Pirouz, A., Langer, R., Orive, G., & Grattoni, A. (2022) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.11.008 · Cited by 46 · see citing works

Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes

Tahbaz, M., & Yoshihara, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.716625 · Cited by 42 · see citing works

Type 1 diabetes and engineering enhanced islet transplantation

Jeyagaran, A., Lu, C., Zbinden, A., Birkenfeld, A. L., Brucker, S. Y., & Layland, S. L. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114481 · Cited by 41 · see citing works

Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes

Samojlik, M. M., & Stabler, C. L. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.039 · Cited by 38 · see citing works

Macroencapsulation devices for cell therapy

Liu, W., Wang, Y., Wang, J.-Q., Lanier, O. L., Wechsler, M., Peppas, N., & Gu, Z. (2022) · Engineering · doi:10.1016/j.eng.2021.10.021 · Cited by 32 · see citing works

Hydrolytically Degradable Microgels with Tunable Mechanical Properties Modulate the Host Immune Response

Coronel, M. M., Martin, K. E., Hunckler, M. D., Kalelkar, P. P., Shah, R. M., & Garcı́a, A. J. (2022) · Small · doi:10.1002/smll.202106896 · Cited by 38 · see citing works

Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering

Krentz, N. A. J., Shea, L. D., Huising, M. O., & Shaw, J. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00170-4 · Cited by 37 · see citing works

Tissue engineering and 3D printing of bioartificial pancreas for regenerative medicine in diabetes.

Soetedjo, A. A. P., Lee, J.-M., Lau, H. H., Goh, G.-L., An, J., Koh, Y., Yeong, W., & Teo, A. (2021) · Trends in endocrinology and metabolism · doi:10.1016/j.tem.2021.05.007 · Cited by 30 · see citing works

An in situ dual-anchoring strategy for enhanced immobilization of PD-L1 to treat autoimmune diseases

Wang, S., Zhang, Y., Wang, Y., Yang, Y., Zhao, S., Sheng, T., Zhang, Y., Gu, Z., Wang, J., & Yu, J. (2023) · Nature Communications · doi:10.1038/s41467-023-42725-1 · Cited by 32 · see citing works

Granular Hydrogels for Harnessing the Immune Response

Widener, A. E., Roberts, A., & Phelps, E. A. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202303005 · Cited by 32 · see citing works

Bioengineering the Vascularized Endocrine Pancreas: A Fine-Tuned Interplay Between Vascularization, Extracellular-Matrix-Based Scaffold Architecture, and Insulin-Producing Cells

Pignatelli, C., Campo, F., Neroni, A., Piemonti, L., & Citro, A. (2022) · Transplant International · doi:10.3389/ti.2022.10555 · Cited by 25 · see citing works

Encapsulation and Immune Protection for Type 1 Diabetes Cell Therapy

Kioulaphides, S., & García, A. J. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115205 · Cited by 30 · see citing works

MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy

Wan, J.-L., Wang, B., Wu, M.-L., Li, J., Gong, R.-M., Song, L.-N., Zhang, H., Zhu, G., Chen, S.-P., Cai, J., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215750 · Cited by 29 · see citing works

Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”

Karpov, D. S., Sosnovtseva, A. O., Pylina, S. V., Bastrich, A., Petrova, D. A., Kovalev, M. A., Shuvalova, A. I., Константиновна, Е. А., & Mokrysheva, N. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417320 · Cited by 29 · see citing works

Immuno-protective vesicle-crosslinked hydrogel for allogenic transplantation

Wang, Y., Huang, R., Lu, Y., Liu, M., & Mo, R. (2024) · Nature Communications · doi:10.1038/s41467-024-49135-x · Cited by 28 · see citing works

Engineering of hybrid spheroids of mesenchymal stem cells and drug depots for immunomodulating effect in islet xenotransplantation

Nguyen, T. T., Pham, D., Park, J., Phung, C. D., Nepal, M. R., Pandit, M., Shrestha, M., Son, Y., Joshi, M., Jeong, T. C., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn8614 · Cited by 28 · see citing works

Emerging local immunomodulatory strategies to circumvent systemic immunosuppression in cell transplantation

Campa‐Carranza, J. N., Paez‐Mayorga, J., Chua, C. Y. X., Nichols, J. E., & Grattoni, A. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2076834 · Cited by 28 · see citing works

Human stem cell derived beta-like cells engineered to present PD-L1 improve transplant survival in NOD mice carrying human HLA class I

Santini-González, J., Castro-Gutiérrez, R., Becker, M. W., Rancourt, C., Russ, H. A., & Phelps, E. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.989815 · Cited by 26 · see citing works

Towards single cell encapsulation for precision biology and medicine

Gupta, P., Alheib, O., & Shin, J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115010 · Cited by 21 · see citing works

Immunomodulation by subcutaneously injected methacrylic acid-based hydrogels and tolerogenic dendritic cells in a mouse model of autoimmune diabetes

Kinney, S. M., Ortaleza, K., Won, S., Licht, B. J. M., & Sefton, M. V. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122265 · Cited by 21 · see citing works

Immunoprotection Strategies in β‐Cell Replacement Therapy: A Closer Look at Porcine Islet Xenotransplantation

Grimus, S., Sarangova, V., Welzel, P. B., Ludwig, B., Seißler, J., Kemter, E., Wolf, E., & Ali, A. (2024) · Advanced Science · doi:10.1002/advs.202401385 · Cited by 21 · see citing works

iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine

Hui, K. K., & Yamanaka, S. (2024) · BioEssays · doi:10.1002/bies.202400072 · Cited by 22 · see citing works

Palmitoylation of PD-L1 Regulates Its Membrane Orientation and Immune Evasion

Zhang, S., Wang, H., Tao, X., Chen, Z., Levental, I., & Lin, X. (2025) · Langmuir · doi:10.1021/acs.langmuir.4c04441 · Cited by 20 · see citing works

Selective HLA knockdown and PD-L1 expression prevent allogeneic CAR-NK cell rejection and enhance safety and anti-tumor responses in xenograft mice

Liu, F., Tarannum, M., Zhao, Y., Zhang, Y. J., Ham, J. D., Lei, K., Qiang, Y., Deng, X., Nguyen, M., Dinh, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63863-8 · Cited by 20 · see citing works

Comprehensive analysis identifies ARHGEF6 as a potential prognostic and immunological biomarker in lung adenocarcinoma

Wang, N., Li, Y., Zhou, X., Wang, X., & Yang, G. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106448 · Cited by 20 · see citing works

Immune-instructive materials as new tools for immunotherapy

Fisher, L. E., Kämmerling, L., Alexander, M. R., & Ghaemmaghami, A. M. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.11.005 · Cited by 19 · see citing works

Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression

Paul, P. K., Das, R., Drow, T., Nylen, E. A., de Souza, A. H., Wang, Z., Wood, M. W., Davis, D. B., Bjorling, D. E., & Galipeau, J. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17162 · Cited by 19 · see citing works

A hydrogel platform for co‐delivery of immunomodulatory proteins for pancreatic islet allografts

Medina, J. D., Barber, G. F., Coronel, M. M., Hunckler, M. D., Linderman, S. W., Quizon, M. J., Ulker, V., Yolcu, E. S., Shirwan, H., & Garcı́a, A. J. (2022) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37429 · Cited by 18 · see citing works

Hydrogel-based approaches to target hypersensitivity mechanisms underlying autoimmune disease

Kim, K. M., D’Elia, A. M., & Rodell, C. B. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115395 · Cited by 18 · see citing works

Engineering β Cell Replacement Therapies for Type 1 Diabetes: Biomaterial Advances and Considerations for Macroscale Constructs

Quizon, M. J., & Garcı́a, A. J. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-094846 · Cited by 18 · see citing works

Delayed graft rejection in autoimmune islet transplantation via biomaterial immunotherapy

Coronel, M. M., Linderman, S. W., Martin, K. E., Hunckler, M. D., Medina, J. D., Barber, G. F., Riley, K., Yolcu, E. S., Shirwan, H., & Garcı́a, A. J. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.07.023 · Cited by 16 · see citing works

Challenges and opportunities in the islet transplantation microenvironment: a comprehensive summary of inflammatory cytokine, immune cells, and vascular endothelial cells

Chen, Q.-D., Liu, L., Zhao, X.-H., Liang, J., & Li, S.-W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1293762 · Cited by 16 · see citing works

Advancements and Challenges in Immune Protection Strategies for Islet Transplantation

Wang, X., Zeng, Z., Li, D., Wang, K., Zhang, W., Yu, Y., & Wang, X. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70048 · Cited by 15 · see citing works

Immune-evasive beta cells in type 1 diabetes: innovations in genetic engineering, biomaterials, and computational modeling

Karaoğlu, İ. C., Duymaz, D., Rashid, M. M., & Kızılel, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1618086 · Cited by 15 · see citing works

Microencapsulated stem cells reduce cartilage damage in a material dependent manner following minimally invasive intra-articular injection in an OA rat model

Johnbosco, C., Karbaat, L., Korthagen, N. M., Warmink, K., Koerselman, M., Coeleveld, K., Becker, M., van Loo, B., Zoetebier, B., Both, S. K., et al. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100791 · Cited by 14 · see citing works

Emerging approaches for the development of artificial islets

Li, J., Sun, L., Bian, F.-K., Pandol, S., & Li, L. (2024) · Smart Medicine · doi:10.1002/smmd.20230042 · Cited by 10 · see citing works

Drug delivery strategies for local immunomodulation in transplantation: Bridging the translational gap

Naaz, A., Turnquist, H. R., Gorantla, V. S., & Little, S. R. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115429 · Cited by 15 · see citing works

Neonatal islets from human PD-L1 transgenic pigs reduce immune cell activation and cellular rejection in humanized nonobese diabetic-scid IL2rγnull mice

Lei, Y., Buerck, L. W., Honarpisheh, M. M., Zhang, Y., Schwinzer, R., Petersen, B., & Seißler, J. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.08.026 · Cited by 14 · see citing works

Long-term functional maintenance of primary hepatocytes in vitro using macroporous hydrogels engineered through liquid-liquid phase separation

Sun, Y., Yin, S., Cui, J., Wang, Z., Han, Y., Ma, D., Wang, S., Wu, J., Cao, Y., Jiang, C., et al. (2024) · Nano Research · doi:10.1007/s12274-023-5940-3 · Cited by 13 · see citing works

Biomaterial-based approaches to engineering immune tolerance

Emerson, A. E., Slaby, E. M., Hiremath, S. C., & Weaver, J. D. (2020) · Biomaterials Science · doi:10.1039/d0bm01171a · Cited by 12 · see citing works

Current Topics of Relevance to the Xenotransplantation of Free Pig Islets

Mou, L., Shi, G., Cooper, D. K. C., Lu, Y., Chen, J., Zhu, S., Deng, J., Huang, Y., Ni, Y., Zhan, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.854883 · Cited by 11 · see citing works

Unveiling a novel type 1 diabetes endotype: Opportunities for intervention

Fiorina, P., & Pozzilli, P. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3536 · Cited by 11 · see citing works

Gene delivery followed by ex vivo lung perfusion using an adeno-associated viral vector in a rodent lung transplant model

Gao, Q., Kahan, R., Gonzalez, T. J., Zhang, M., Alderete, I. S., DeLaura, I. F., Kesseli, S. J., Song, M., Asokan, A., Barbas, A. S., et al. (2023) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2023.08.047 · Cited by 11 · see citing works

Translation of cell therapies to treat autoimmune disorders

Mehta, J. M., Hiremath, S. C., Chilimba, C., Ghasemi, A., & Weaver, J. D. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115161 · Cited by 11 · see citing works

Engineering Strategies for Allogeneic Solid Tissue Acceptance

Sousa, A. R., Mano, J. F., & Oliveira, M. B. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.03.005 · Cited by 10 · see citing works

Comparison of Four Different Preparation Methods for Making Injectable Microgels for Tissue Engineering and Cell Therapy

Hamami, R., Yameen, H. S., Gargioli, C., & Seliktar, D. (2022) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-022-00261-2 · Cited by 10 · see citing works

Unlocking Transplant Tolerance with Biomaterials

Pham, J. A., & Coronel, M. M. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400965 · Cited by 8 · see citing works

From Edmonton to Lantidra and beyond: immunoengineering islet transplantation to cure type 1 diabetes

Mbaye, E. H. A., Scott, E. A., & Burke, J. A. (2025) · Frontiers in Transplantation · doi:10.3389/frtra.2025.1514956 · Cited by 8 · see citing works

Application of hydrogels in cancer immunotherapy: a bibliometric analysis

Liu, X., Zhou, Q., Yang, Y., & Chen, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1433050 · Cited by 7 · see citing works

A durable immuno-protective core-shell microgel for the enhanced pancreatic islet transplantation in diabetes therapy

Hu, Z., Luo, Y., Junaid, M., Xu, R., Chen, Y., Yao, J., Ni, R., Zhu, T., Zhang, H., Ding, H., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.169527 · Cited by 5 · see citing works

Modulating immune response for the prevention and treatment of type 1 diabetes

Vohidova, D., Desai, P., Lozano, A. M., & Veiseh, O. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1715863 · Cited by 5 · see citing works

Immune modulation for β-cell replacement in type 1 diabetes

Yang, Q., Song, Y.-H., Markmann, J., & Lei, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1785523 · Cited by 5 · see citing works

Bending the Rules: Amplifying PD-L1 Immunoregulatory Function Through Flexible Polyethylene Glycol Synthetic Linkers

Racca, N. M., Dontu, A., Riley, K., Yolcu, E. S., Shirwan, H., & Coronel, M. M. (2024) · Tissue Engineering Part A · doi:10.1089/ten.tea.2023.0274 · Cited by 5 · see citing works

Engineering of Trophoblast Extracellular Vesicle-Delivering Hydrogels for Localized Tolerance Induction in Cell Transplantation

Hiremath, S. C., & Weaver, J. D. (2023) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-023-00778-8 · Cited by 5 · see citing works

A new paradigm in transplant immunology: At the crossroad of synthetic biology and biomaterials

Zhang, Z., Ding, L.-Y., Zuo, X.-L., Feng, H., & Xia, Q. (2023) · Med · doi:10.1016/j.medj.2023.05.002 · Cited by 5 · see citing works

Efficacy of chemically induced human hepatic progenitor cells from diseased liver against nonalcoholic steatohepatitis model

Miyamoto, D., Matsuguma, K., Nagai, K., Miyoshi, T., Hara, T., Matsushima, H., Soyama, A., Ochiya, T., Miyazaki, Y., & Eguchi, S. (2024) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.12046 · Cited by 4 · see citing works

Molecularly Tailored Interface for Long‐Term Xenogeneic Cell Transplantation

Perikamana, S. K. M., Seale, N. M., Hoque, J., Ryu, J. H., Kumar, V., Shih, Y.-R. V., & Varghese, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202108221 · Cited by 4 · see citing works

The type 1 diabetes immune niche: Immunomodulatory biomaterial design considerations for beta cell transplant therapies

Hilburger, C. E., Rosenwasser, M. J., & Delcassian, D. (2022) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2022.100063 · Cited by 3 · see citing works

Targeted immunomodulation for chronic diseases through advanced delivery platforms

Girela, M., Gupta, D., Grattoni, A., & Chua, C. Y. X. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2580443 · Cited by 3 · see citing works

Biophysical quantification of reorganization dynamics of human pancreatic islets during co-culture with adipose-derived stem cells

Torres‐Castro, K., Azimi, M. S., Varhue, W. B., Honrado, C., Peirce, S. M., & Swami, N. S. (2022) · The Analyst · doi:10.1039/d2an00222a · Cited by 3 · see citing works

Generation of fluorescent and bioluminescent induced pluripotent stem cells with their application in tracking organoid development

Wang, L., Yu, Z., Zhang, Y., Yang, Z., Zhao, J., Kong, D., & Wang, Y. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102849 · Cited by 1 · see citing works

Antigen-delivering biomaterials for local enrichment and reprogramming of immune cells

Wheeler, S. N., & Morris, A. H. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115042 · Cited by 1 · see citing works

Localized immunomodulation with cytokine-producing cells to mitigate foreign body responses in rodents and a nonhuman primate

Kim, B., Vohidova, D., Nash, A., Chan, Y. S., Fleury, S., Deo, S., Murungi, D., Rios, P., Joshi, I., Nasir, H., et al. (2026) · Science Advances · doi:10.1126/sciadv.aec7053 · Cited by 2 · see citing works

Localized immunomodulation with cytokine-producing cells to mitigate host immune rejection responses in rodents and a non-human primatePreprint

Kim, B., Vohidova, D., Nash, A., Chan, Y. S., Fleury, S., Deo, S., Murungi, D., Rios, P., Joshi, I., Nasir, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.13.682221 · Cited by 1 · see citing works

Selecting Biocompatible Biomaterials for Stem Cell-Derived β-Cell Transplantation

de Vries, R. H. W., & van Apeldoorn, A. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_6

Gamma Irradiation of Poly(lactide‐co‐glycolide) Scaffolds Reduces the Mechanical Stability and Function of Islet Grafts in Diabetic Nonhuman Primates

King, J. L., Spencer, C., Youngblood, R. L., Crumley, K. M., Bealer, E. J., Rios, P., Joshi, I., Ghani, S., Isa, D., McGarrigle, J. J., et al. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.70134

Modern approaches to creating a microenvironment for islets of langerhanes in the pancreas in order to increase functional activity during transplantation

Tselousova, Y. M., & Kashina, A. (2025) · Scientific Bulletin of the Omsk State Medical University · doi:10.61634/2782-3024-2025-17-64-77

Surgical Approaches for Heart Transplantation in Cardiomyopathy Patients: Current Trends

Cao, J. N., He, S. N., Wang, H. Y., Yang, H., Lei, Z., Long, C., & Feng, Y. (2026) · The Heart Surgery Forum · doi:10.31083/hsf50679

Harnessing Lessons from Gel-Based and Advanced Biomaterial Therapeutics to Enable Direct Cellular Reprogramming

González‐Nieto, D., Pérez‐Rigueiro, J., Rojo, F. J., Panetsos, F., & Guinea, G. V. (2026) · Gels · doi:10.3390/gels12060486

Islet-Targeted ZnT8 Antibodies Protect Pancreatic β-Cells From Inflammatory Stress

Guo, Z., Kasinathan, D., Yun, S., Golson, M. L., & Fu, D. (2026) · Diabetes · doi:10.2337/db26-0183

Advancing Type 1 Diabetes Treatment: 3 PM‐Oriented Innovations in Islet Transplantation and Biomaterial Engineering

Sarvestani, F. S., Yaghobi, R., Maharlooei, M. K., Golshan, M., & Karimi, M. H. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70215

Advances in nanomaterial-based delivery systems for inducing transplantation tolerance

Li, Q., Zhang, Y., Wu, J., Huang, D., & Qi, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1908621

La thérapie cellulaire du diabète de type 1 en 2035, évolutions scientifiques et nouvelles indications à court terme

Lablanche, S. (2026) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2026.09.023

Engineering an Implantable Bioartificial Pancreas to Balance Transport, Containment, and Retrieval

Shi, H., Li, Y., He, C., & Sun, B. (2026) · Artificial Organs · doi:10.1111/aor.70254

Engineering stem cell-derived islets for type 1 diabetes: genetic strategies for immune evasion and stress resilience

Leavens, C. M., Chamberlain, C. S., Kapadia, D., Jurrens, N., Estrada, E. J., Talerico, K., Arroyo, M., -, P. D., & Odorico, J. S. (2026) · Regenerative Medicine · doi:10.1080/17460751.2026.2751695

Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression

Batra, L., Shrestha, P., Zhao, H., Woodward, K. B., Togay, A., Tan, M., Grimany-Nuno, O., Malik, M. T., Coronel, M. M., Garcı́a, A. J., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000055 · Cited by 42 · see citing works

PD-L1-engineered pancreatic islet grafts overcome rejection in allogeneic recipients

Batra, L., Shrestha, P., Yolcu, E. S., Zhao, H., Bowen, W. S., Woodward, K. B., Coronel, M. M., Tan, M., Garcı́a, A. J., & Shirwan, H. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.200.supp.176.6 · Cited by 1 · see citing works

IMMUNOMODULATION WITH SA-PDL1 PROTEIN ON PANCREATIC ISLETS PROMOTES INDEFINITE GRAFT SURVIVAL IN ALLOGENEIC RECIPIENTS

Batra, L., Shrestha, P., Zhao, H., Woodward, K. B., Togay, A., Tan, M., Grimany-Nuno, O., Malik, M. T., Coronel, M. M., Garcı́a, A. J., et al. (2020) · Transplantation · doi:10.1097/01.tp.0000699084.35417.96

The Transient Display of a Chimeric PD-L1 Protein on Pancreatic Islets Promotes Indefinite Survival in Allogeneic Recipients

Batra, L., Shrestha, P., Yolcu, E. S., Zhao, H., Bowen, W. S., Woodward, K. B., Coronel, M. M., Tan, M., Garcı́a, A. J., & Shirwan, H. (2018) · Transplantation · doi:10.1097/01.tp.0000543248.46167.ff · Cited by 3 · see citing works

Synthetic Immunomodulatory Biomaterials to Improve Islet Graft Survival

Coronel, M. M., Weaver, J. D., Hunckler, M. D., Yolcu, E. S., Shirwan, H., & Garcı́a, A. J. (2018) · Transplantation · doi:10.1097/01.tp.0000542900.67611.3f · Cited by 1 · see citing works